“Generic Zepbound”
No approved generic tirzepatide existed as of September 2026.
Question brief
Is this tirzepatide what the page says it is?
Three separate things need checking: what exactly the product is, whether the FDA approved it, and whether it is being sold the lawful way, with a prescription. For example, a website may sell a vial it calls tirzepatide with a label saying “for research use only.” Even if the chemical inside is what the label says, it is not an approved medicine, and buying it to inject is not a legal way to get treatment. In the same way, a pharmacy can hold a proper state licence and still hand you a copy it made itself, which is not the maker’s own Mounjaro or Zepbound.
Offer check
ProductPeopleSource
Exact namerequired
Prescriptionrequired
Licence checkavailable
The current position
Mounjaro and Zepbound were the two FDA-approved tirzepatide brands.
Where does compounding fit?
Compounded medicines can meet a specific patient need, but they are not FDA-approved. The FDA does not verify their safety, effectiveness, or quality before they are marketed.
While tirzepatide was officially in short supply, pharmacies were allowed to make their own copies. The FDA declared that shortage over in December 2024. Pharmacies were then given deadlines to stop making everyday copies of tirzepatide, and those deadlines passed in early 2025. A pharmacy may still make a version for one patient when the prescriber decides a change matters for that person specifically.
Pause when the language gets slippery
“Research use only”
That label does not turn a chemical sold for human use into treatment.
“FDA registered”
Registration is not FDA approval of a facility or product.
No prescription
A prescription medicine cannot lawfully be dispensed without a prescription.
A plain test
Those names create a trail that can be checked with state boards and FDA records.
Ready for the next piece?
Next: how to check a care service